Michael Kneba
Hat mitgewirkt an:
-
Antikörpertherapie in der Hämatologie und Onkologie
-
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
-
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV